The U.S. Food and Drug Administration has approved ViiV Healthcare's Tivicay PD (dolutegravir) for the treatment of HIV-1 infection in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE